Viagra's Second Act: A Heart Drug's Surprising Longevity Story
The PDE5 inhibitors are vascular drugs whose most famous effect happens to be below the belt — and new evidence links them to lower cancer risk and the earliest stage of heart disease.
William H. Light, MD
8/8/20261 min read
Most people file the PDE5 inhibitors — sildenafil (Viagra) and tadalafil (Cialis) — under one heading. But they are better understood as vascular drugs whose most famous effect happens to be below the belt. Remember the origin story: sildenafil was built for angina. The erectile effect was the side effect.
The mechanism ties a whole philosophy of longevity together. These drugs prolong nitric-oxide signaling — nitric oxide being the master molecule of vascular health, the one that keeps the endothelium, the living lining of every artery you own, working properly. Endothelial dysfunction is the first step in atherosclerosis, appearing years before plaque. A drug that supports that system is acting on the earliest stage of the disease that kills more people than anything else.
There's a clinical pearl here every man over 40 should know: an erection is a vascular event, and the penile arteries are small. New erectile dysfunction after 40 can precede a heart attack by three to five years. A good internist treats it as a cardiovascular finding, not just a quality-of-life one.
And then the newest twist. In 2026, researchers at the Weizmann Institute published a genuinely novel mechanism in Cancer Research: the same rise in cyclic GMP that these drugs produce traps cholesterol inside the lysosome of cancer cells — starving them of the raw material they need to spread. It dovetails with human genetic evidence suggesting PDE5 inhibition is associated with markedly lower colorectal and gastric cancer risk, with no increased risk across the board. The old melanoma scare, meanwhile, appears to be confounding, not cause.
The honest bottom line: none of this is a reason to self-prescribe, and the trial-grade proof isn't all in. But a cheap, generic, decades-old pill that improves the earliest stage of heart disease and may make the body a harder place for cancer to spread is a remarkable story — and a near-perfect example of this book's thesis that the field keeps rewarding the boring old drugs.
Adapted from Outlast by William H. Light, MD. Talk to your physician — this is a real drug with real interactions, including a dangerous one with nitrates.